NIH-funded research NIH-funded research

Cytoskeletal connectors: uncovering how cell skeletons move and communicate in disease

Official title: Cytoskeletal connectors: Deciphering the fundamental mechanisms of cytoskeletal dynamics and transport

Funded at Salk Institute for Biological Studies · NIH-11428743 · Data updated 2026-11-12

A research project at a leading biology institute studies how the cell’s skeleton proteins work together to move cargo and control cell behavior, with a focus on cancers and related diseases.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSalk Institute for Biological Studies
NIH-funded
Lab location1 site (La Jolla, UNITED STATES)
Project startJune 12, 2026
Project endMarch 31, 2031
Funding year2026
Award (this year)$515,625
NIH project number1R35GM165848-01
Project IDNIH-11428743 on NIH RePORTER

Who could benefit from this research

Could help

This research is basic science; patients with cancer or neurodevelopmental/neurodegenerative diseases could benefit from future therapies informed by these mechanisms.

Less likely to help

Direct benefits to patients are not guaranteed during basic discovery, and results may take time to translate.

What this research studies

This project will look at how actin and microtubule networks are connected by spectraplakin proteins and how their ATPase domains may actively drive movement and signaling. Researchers will use structural biology, biochemistry, and cell biology to understand how these connectors influence neuron development, cancer progression, and cell division. The work could reveal new targets to interfere with abnormal cell movement and growth in cancer. It aims to move beyond viewing connectors as passive linkers to uncover their active roles.

Why it matters

Potential benefit: If successful, findings could lead to new approaches for treating cancers by targeting cytoskeletal connectors.

How similar studies have gone: Previous work has hinted that cytoskeletal connectors have active roles, but this program aims to deepen understanding and translate it toward therapies.

Where this research is happening

  • Salk Institute for Biological Studies
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Kendrick, Agnieszka Anastazja — Salk Institute for Biological Studies
  • Study coordinator: Kendrick, Agnieszka Anastazja

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.